Last price paid | 1.09 | |
Change | +6.86% [ +0.07 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 18.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 17.07.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +73.08% |
Year to date (YTD) | n.a. |
1 month | n.a. |
3 months | n.a. |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.65 |
Underlying price on issue | 255.60 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1338518033 |
Symbol | IRORTZ |
Security | 133851803 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Roche Hldg G, CH0012032048 |
Underlying ISIN | CH0012032048 |
Funding level | 223.837500 |
Stop-loss level | 230.359500 |
Distance to stop-loss level | 17.55% |
Long/Short type | Long |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 15.07.2024 |
Premium | 0.25% |
Premium p.a. | n.a. |
Leverage | 4.97 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 55.562500 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
KUEHNE & NAGEL | 265.50 |
NOVARTIS N | 96.37 |
LOGITECH INT. | 80.62 |
Givaudan | 4'306.00 |
GEBERIT N | 565.60 |
Name | Price |
---|---|
Swiss Re | 106.25 |
ROCHE GS | 279.60 |
ZURICH INSURANCE | 474.90 |
Alcon AG | 80.42 |
SWISSCOM N | 535.00 |